olmesartan has been researched along with ascorbic acid in 2 studies
Studies (olmesartan) | Trials (olmesartan) | Recent Studies (post-2010) (olmesartan) | Studies (ascorbic acid) | Trials (ascorbic acid) | Recent Studies (post-2010) (ascorbic acid) |
---|---|---|---|---|---|
841 | 185 | 554 | 45,261 | 2,497 | 11,176 |
Protein | Taxonomy | olmesartan (IC50) | ascorbic acid (IC50) |
---|---|---|---|
Chain A, Hyaluronidase, phage associated | Streptococcus pyogenes | 1000 | |
Urease | Canavalia ensiformis (jack bean) | 8.59 | |
Solute carrier family 23 member 1 | Homo sapiens (human) | 156 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Aso, Y; Inukai, T; Inukai, Y; Matsutomo, R; Nakamachi, T; Takahashi, K; Takanashi, K; Takebayashi, K; Wakabayashi, S; Yoshida, N | 1 |
2 other study(ies) available for olmesartan and ascorbic acid
Article | Year |
---|---|
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers effectively and directly potentiate superoxide scavenging by polymorphonuclear leukocytes from patients with type 2 diabetes mellitus.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Ascorbic Acid; Blood Glucose; Captopril; Diabetes Mellitus, Type 2; Female; Free Radical Scavengers; Humans; Imidazoles; In Vitro Techniques; Male; Middle Aged; Neutrophils; Superoxide Dismutase; Superoxides; Tetrazoles; Thiazepines | 2005 |